Cambridge Heart (NSDQ:CAMH) said chairman and interim president Roderick de Greef and former president & CEO Ali Haghighi-Mood have both resigned from the medical device company.
Baxter
Legal: Fresenius is off the hook as Baxter fails to recoup $24M infringement decision
Baxter warns on dialysis device
Baxter meets The Street with Q3 results
CSL settles plasma price-fixing case for $64M
Layoffs: Baxter axes nearly 100 from New York facility amid FDA inquiry
Baxter recalls lock caps on contamination concerns, gets FDA’s highest-risk label
Baxter can question FDA official in plasma therapy price-fixing case
Baxter names Young new treasurer | Personnel Moves
Baxter makes a smaller buy with $9.5M acquisition of FlowSense
Corrected September 11, 2013, at 3:30 p.m.*